Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Reneo Pharmaceuticals (RPHM) Short Interest Ratio & Short Volume

Reneo Pharmaceuticals logo

Reneo Pharmaceuticals Short Interest Data

Reneo Pharmaceuticals (RPHM) has a short interest of 3.40 million shares, representing 15.65% of the float (the number of shares available for trading by the public). This marks a 5.26% increase in short interest from the previous month. The short interest ratio (days to cover) is 20.8, indicating that it would take 20.8 days of the average trading volume of 250,384 shares to cover all short positions.

Current Short Interest
3,400,000 shares
Previous Short Interest
3,230,000 shares
Change Vs. Previous Month
+5.26%
Dollar Volume Sold Short
$4.45 million
Short Interest Ratio
20.8 Days to Cover
Last Record Date
September 15, 2024
Outstanding Shares
33,430,000 shares
Float Size
21,720,000 shares
Short Percent of Float
15.65%
Today's Trading Volume
437,523 shares
Average Trading Volume
250,384 shares
Today's Volume Vs. Average
175%
Short Selling Reneo Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

RPHM Short Interest Over Time

RPHM Days to Cover Over Time

RPHM Percentage of Float Shorted Over Time

Reneo Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20243,400,000 shares $4.45 million +5.3%15.7%20.8 $1.31
8/31/20243,230,000 shares $4.78 million -0.9%14.9%26.2 $1.48
8/15/20243,260,000 shares $5.09 million +0.6%15.0%25.2 $1.56
7/31/20243,240,000 shares $4.83 million No Change14.9%12.6 $1.49
7/15/20243,240,000 shares $4.92 million -10.0%14.9%12.2 $1.52
6/30/20243,600,000 shares $5.44 million +0.6%16.6%13.4 $1.51
6/15/20243,580,000 shares $5.94 million +2.3%16.5%14.9 $1.66
5/31/20243,500,000 shares $5.81 million -3.6%16.1%14.2 $1.66
5/15/20243,630,000 shares $5.81 million +18.2%16.7%13.7 $1.60
4/30/20243,070,000 shares $5.13 million +4.4%13.8%18.7 $1.67
4/15/20242,940,000 shares $4.88 million +0.7%13.2%13.8 $1.66
3/31/20242,920,000 shares $4.85 million +3.6%13.1%10.7 $1.66
3/15/20242,820,000 shares $4.68 million +8.9%12.7%5.6 $1.66
2/29/20242,590,000 shares $4.27 million +29.5%11.7%2.5 $1.65
2/15/20242,000,000 shares $3.34 million +22.7%9.0%1.9 $1.67
1/31/20241,630,000 shares $2.67 million +10.1%7.4%1.5 $1.64
1/15/20241,480,000 shares $2.49 million -15.4%6.7%1.4 $1.68
12/31/20231,750,000 shares $2.80 million -50.3%7.8%1.8 $1.60
12/15/20233,520,000 shares $5.00 million +30.9%15.6%4 $1.42
11/30/20232,690,000 shares $17.05 million +8.0%13.9%13.1 $6.34
11/15/20232,490,000 shares $16.46 million +5.5%12.8%15 $6.61
10/31/20232,360,000 shares $19.09 million +3.1%12.0%15.6 $8.09
10/15/20232,290,000 shares $16.97 million +12.3%11.6%14.9 $7.41
9/30/20232,040,000 shares $15.53 million -1.9%10.4%13.7 $7.62
9/15/20232,080,000 shares $15.25 million +2.5%10.6%14.7 $7.33
8/31/20232,030,000 shares $12.22 million +16.7%10.3%12.2 $6.02
8/15/20231,740,000 shares $9.81 million +18.4%8.9%11 $5.64
7/31/20231,470,000 shares $11.80 million +20.5%7.5%9.3 $8.03
7/15/20231,220,000 shares $8.98 million +36.9%6.2%7.4 $7.36
6/30/2023891,200 shares $5.85 million +83.1%6.0%5.5 $6.56
6/15/2023486,700 shares $3.49 million -12.3%3.3%3.4 $7.18
5/31/2023555,200 shares $4.44 million +117.2%5.1%5.4 $8.00
5/15/2023255,600 shares $2.10 million +121.1%2.3%2.4 $8.20
4/30/2023115,600 shares $1.18 million -9.2%1.2%1.3 $10.22
4/15/2023127,300 shares $865.64 thousand -7.8%1.1%1.8 $6.80
3/31/2023138,100 shares $825.84 thousand +19.5%1.2%2.4 $5.98
3/15/2023115,600 shares $502.86 thousand +21.3%1.1%2.1 $4.35
2/28/202395,300 shares $289.71 thousand +0.5%0.9%2 $3.04
2/15/202394,800 shares $265.44 thousand +19.6%0.9%3 $2.80
1/31/202379,300 shares $214.90 thousand -2.3%0.7%2.7 $2.71
Why Trump’s “Smart Dollar” could rewrite the rules (Ad)

MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel

Get the three steps to take this month to put yourself on the right side of this $30 trillion money
1/15/202381,200 shares $211.12 thousand +59.2%0.7%3.1 $2.60
12/30/202251,000 shares $118.83 thousand +6.9%0.5%2.3 $2.33
12/15/202247,700 shares $104.94 thousand -24.3%0.4%2.6 $2.20
11/30/202263,000 shares $140.49 thousand -7.2%0.6%3 $2.23
11/15/202267,900 shares $177.22 thousand -3.1%0.6%3 $2.61
10/31/202270,100 shares $246.75 thousand -7.6%0.7%2.6 $3.52
10/15/202275,900 shares $227.70 thousand +14.0%0.7%1.6 $3.00
9/30/202266,600 shares $223.11 thousand -14.5%0.6%1.4 $3.35
9/15/202277,900 shares $377.82 thousand +8.7%0.7%1.1 $4.85
8/31/202271,700 shares $225.86 thousand -2.2%0.7%0.9 $3.15
8/15/202273,300 shares $209.64 thousand -35.0%0.7%0.8 $2.86
7/31/2022112,800 shares $398.18 thousand -18.4%1.0%1.1 $3.53
7/15/2022138,300 shares $409.37 thousand -26.0%1.3%1.4 $2.96
6/30/2022186,900 shares $495.29 thousand -49.8%1.7%1.9 $2.65
6/15/2022372,600 shares $823.45 thousand -4.4%3.4%4.1 $2.21
5/31/2022389,900 shares $807.09 thousand +10.7%3.6%5.5 $2.07
5/15/2022352,300 shares $753.92 thousand +5.2%3.2%5.3 $2.14
4/30/2022334,900 shares $776.97 thousand +32.5%3.1%7.1 $2.32
4/15/2022252,800 shares $652.22 thousand +2.7%2.3%5.8 $2.58
3/31/2022246,100 shares $723.53 thousand +11.5%2.3%5.8 $2.94
3/15/2022220,800 shares $779.42 thousand +6.7%2.0%4.8 $3.53
2/28/2022206,900 shares $997.26 thousand +3.9%1.9%3.7 $4.82
2/15/2022199,200 shares $1.04 million +17.0%1.8%3.6 $5.21
1/31/2022170,300 shares $1.06 million -21.2%1.6%3 $6.21
1/15/2022216,000 shares $1.94 million -13.2%2.0%4.2 $8.98
12/31/2021248,900 shares $2.13 million -14.1%2.3%5.1 $8.55
12/15/2021289,800 shares $2.20 million +4.3%2.7%6 $7.58
11/30/2021277,800 shares $1.91 million -1.0%2.5%7.9 $6.88
11/15/2021280,600 shares $2.29 million -0.1%2.6%3.8 $8.17
10/29/2021280,900 shares $1.84 million -9.2%2.6%4 $6.56
10/15/2021309,200 shares $1.99 million -73.6%2.8%4.5 $6.44
9/30/20211,170,000 shares $8.72 million No Change10.6%17.2 $7.45
9/15/20211,170,000 shares $8.95 million +3.5%10.6%14.7 $7.65
8/31/20211,130,000 shares $12.51 million -1.7%10.3%12.3 $11.07
8/13/20211,150,000 shares $9.56 million No Change10.5%21.3 $8.31

RPHM Short Interest - Frequently Asked Questions

What is Reneo Pharmaceuticals' current short interest?

Short interest is the volume of Reneo Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 3,400,000 shares of RPHM short. 15.65% of Reneo Pharmaceuticals' shares are currently sold short. Learn More on Reneo Pharmaceuticals' current short interest.

What is a good short interest ratio for Reneo Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPHM shares currently have a short interest ratio of 21.0. Learn More on Reneo Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Reneo Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.65% of Reneo Pharmaceuticals' floating shares are currently sold short.

Is Reneo Pharmaceuticals' short interest increasing or decreasing?

Reneo Pharmaceuticals saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 3,400,000 shares, an increase of 5.3% from the previous total of 3,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Reneo Pharmaceuticals' float size?

Reneo Pharmaceuticals currently has issued a total of 33,430,000 shares. Some of Reneo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Reneo Pharmaceuticals currently has a public float of 21,720,000 shares.

How does Reneo Pharmaceuticals' short interest compare to its competitors?

15.65% of Reneo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Reneo Pharmaceuticals: Humacyte, Inc. (26.12%), Editas Medicine, Inc. (9.12%), Alpha Teknova, Inc. (26.11%), Aerovate Therapeutics, Inc. (21.72%), ProQR Therapeutics N.V. (0.34%), SOPHiA GENETICS SA (0.08%), Annexon, Inc. (8.98%), Organigram Global Inc. (6.14%), enGene Holdings Inc. (0.02%), Tiziana Life Sciences Ltd (1.04%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply Company ($2.07 billion), International Paper Company ($2.01 billion), AppLovin Corporation ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks.

What does it mean to sell short Reneo Pharmaceuticals stock?

Short selling RPHM is an investing strategy that aims to generate trading profit from Reneo Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Reneo Pharmaceuticals?

A short squeeze for Reneo Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RPHM, which in turn drives the price of the stock up even further.

How often is Reneo Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPHM, twice per month. The most recent reporting period available is September, 15 2024.




This page (NASDAQ:RPHM) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners